Ebru OFLUOĞLU, Hatice PAŞAOĞLU, Murat ERDEN, Atiye ÇENGEL, Murat ÖZDEMİR, Emre DURAKOĞLUGİL, Mustafa N. İLHAN

Akut miyokard enfarktüsünde genel kardiak biyokimyasal belirteçlerle kıyaslandığında heart-type fatty acid-binding protein'in rolü

Aim: To investigate the clinical implications of serum heart-type fatty acid-binding protein (H-FABP) compared to myoglobin, cardiac troponin I (cTnI), and creatine kinase MB isoenzyme (CK-MB) in patients with early phase acute myocardial infarction (AMI). Material and Methods: Patients were grouped clinically according to the American College of Cardiology/European Society of Cardiology new definition of myocardial infarction (MI) and by clinician diagnosis of MI. Serum concentrations of H-FABP, myoglobin, cTnI, and CK-MB were determined in 21 patients with AMI and 44 non-AMI patients. From each patient 3 blood samples were obtained 1-2, 3, and 6 h after the onset chest pain. The samples were compared to those of 20 age-matched healthy subjects. All the patients and healthy subjects had normal renal function. Results: At 1-2, 3, and 6 h after the onset of AMI, similar to myoglobin, the diagnostic sensitivity and specificity of H-FABP were higher than those of cTnI and CK-MB. Greater receiver operating characteristic (ROC) curve areas for the diagnosis of MI, by both sets of criteria, were obtained for H-FABP and myoglobin compared to both cTnI and CK-MB. Conclusion: H-FABP and myoglobin are reliable biochemical markers for superacute phase AMI and the changes in their serum concentrations have clinical significance in the diagnosis of AMI.

The role of heart-type fatty acid-binding protein (H-FABP) in acute myocardial infarction (AMI) compared to conrentional cardiac biochemical markers

PDF

___

1. Chan CPY, Cheng WS, Glats JFC. Early diagnosis of acute myocardial infarction using immunosensors and immunotests. Anal Lett 2003; 36: 1987-2004.
2 . Apple FS, Murakami M, Panteghini M, Christenson RH, Dati F, Mair J et al. On behalf of the IFCC Committee on Standardization of Markers of Cardiac Damage. International survey on the use of cardiac markers. Clin Chem 2001; 47: 587-8.
3. Watanabe T, Ohkubo Y, Matsuoka H, Kimura H, Sakai Y, Ohkaru Y et al. Development of simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin Biochem 2001; 3: 257-63.
4. Mair J, Artnct-Dworzak E, Lechleitner P, Morass B, Smidt J, Wagner I. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462-68.
5. Van Nieuwenhoven FA, Kleine AH, Wodzing KWH. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92: 2848-54.
6. Murtiny V, Karmen A. Evaluation of troponin T as a new cardiac marker relative to cardiac enzyme markers. Clin Chem 1995; 41:S 59.
7. Wu AHB, Feng YJ, Contois JH, Pervaiz J. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996; 26: 291-300.
8. Bertinchant JP, Polge A. Diagnostic and prognostic value of hearttype fatty acid-binding protein (H-FABP), an early biochemical marker of myocardial injury. Arch Mal Coeur Vaiss 2005; 98:1225-3.
9. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid-binding protein; diagnostic assays and clinical applications. Clin Chem 2006; 52: 19-29.
10. Iida K, Nagao K, Uchiyama T, Kushiro T. Relationship between heart-type fatty acid-binding protein levels and the risk of death in patients with serious condition on arrival at the emergency department. Intern Med 2005; 44: 1039-45.
11. The Joint European Society of Cardiology/ American College of Cardiology Committee. Myocardial Infarction Redefined – A consensus document of the joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
12. Meng X, Ming M, Wang E. Heart fatty acid binding-protein as a marker for postmortem detection of early myocardial damage. Forensic Science Int (in press).
13. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in Coronary Artery Disease. Clin Chem 1999; 45: 1104-2.
14. Apple FS, Murakami M, Panteghini M, Christenson RH, Dati F, Mair J, Wu AHB. On behalf of the IFCC Committee on standardization of Markers of Cardiac Damage. Clin Chem 2001;47: 587-88.
15. Collinson PO, Stubbs PJ, Kessler AC. Multicenter evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice. Heart 2003; 89: 280-86.
16. Yamamoto M, Comiyama N, Koizumi T, Nameki M, Yamamoto Y, Toyoda T et al. Usefulness of rapid quantitative measurement of myoglobin and troponin T in early diagnosis of Acute Myocardial Infarction. Circ J 2004; 68: 639-44.
17. Kemp M, Donovan J, Higham H, Hooper J. Biochemical markers of myocardial injury. Br J Anaesth 2004; 93: 63-73.
18. Ishii J, Wong JH, Naruse H, Taga S, Kinoshita M , Kurokawa H et al. Serum concentration of myoglobin vs. human heart type fattyacid binding-protein in early detection of acute myocardial infarction. Clin Chem 1997; 43: 1372-78.
19. Glatz JFC, van der Vusse GJ, Simoons ML, Kragton JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998; 272: 87-92.
20. Bertinchant JP, Polge A. Diagnostic and prognostic value of hearttype fatty acid-binding protein (H-FABP), an early biochemical marker of myocardial injury. Arch Mal Coeur Vaiss 2005; 98:1225-31.
21. Alhadi HA, Fox KAA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid binding-protein. Q J Med 2004; 97: 187-198.
22. Alansari SE, Croal BL. Diagnostic value of heart fatty acid binding protein and myoglobin in patients admitted with chest pain. Ann Clin Biochem 2004; 41: 391-96.
23. Xiao HG, Huang ZH, Liu HX, Lin YP. Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction. Di Yi Jun Yi Da Xue Xue BaO 2005; 25: 550-51.
24. Ishii J, Ozaki Y, Lu J, Kitagawa F, Kuno T, Nakano T et al. Prognostic value of serum concentration of heart-type fatty acidbinding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005; 51:1397-1404.
25. Chan CP, Sanderson JE, Glatz JF, Cheng WS, Hempel A, Renneberg R. A superior early myocardial infarction marker. Human heart-type fatty acid binding protein. Z Cardiol 2004; 93:388-397.
26. Glatz JPC, Kleine AH, Van Nieuwenhoven FA, Hermens WT, Van Dieljen-Visser MP, Van Der Vusse GJ et al. Fatty acid binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994; 71: 135-140.
27. Aartsen WM, Pelsers MMAL, Hermens WT. Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Eur J Physiol 2000; 439: 422-39.67
Vol: 37 No: 2 Heart-Type Fatty Acid-Binding Protein in Acute Myocardial Infarction April 2007